全文获取类型
收费全文 | 5305篇 |
免费 | 385篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 31篇 |
儿科学 | 160篇 |
妇产科学 | 97篇 |
基础医学 | 1058篇 |
口腔科学 | 65篇 |
临床医学 | 424篇 |
内科学 | 1074篇 |
皮肤病学 | 149篇 |
神经病学 | 553篇 |
特种医学 | 141篇 |
外科学 | 446篇 |
综合类 | 15篇 |
一般理论 | 1篇 |
预防医学 | 461篇 |
眼科学 | 82篇 |
药学 | 352篇 |
中国医学 | 4篇 |
肿瘤学 | 589篇 |
出版年
2023年 | 28篇 |
2022年 | 48篇 |
2021年 | 86篇 |
2020年 | 55篇 |
2019年 | 120篇 |
2018年 | 127篇 |
2017年 | 82篇 |
2016年 | 104篇 |
2015年 | 137篇 |
2014年 | 164篇 |
2013年 | 245篇 |
2012年 | 389篇 |
2011年 | 409篇 |
2010年 | 201篇 |
2009年 | 236篇 |
2008年 | 375篇 |
2007年 | 393篇 |
2006年 | 397篇 |
2005年 | 378篇 |
2004年 | 412篇 |
2003年 | 343篇 |
2002年 | 329篇 |
2001年 | 48篇 |
2000年 | 33篇 |
1999年 | 56篇 |
1998年 | 80篇 |
1997年 | 46篇 |
1996年 | 48篇 |
1995年 | 57篇 |
1994年 | 36篇 |
1993年 | 28篇 |
1992年 | 15篇 |
1991年 | 24篇 |
1990年 | 17篇 |
1989年 | 15篇 |
1988年 | 9篇 |
1987年 | 9篇 |
1986年 | 10篇 |
1985年 | 8篇 |
1984年 | 9篇 |
1983年 | 10篇 |
1982年 | 9篇 |
1981年 | 11篇 |
1980年 | 9篇 |
1979年 | 6篇 |
1975年 | 5篇 |
1974年 | 9篇 |
1971年 | 6篇 |
1970年 | 5篇 |
1966年 | 3篇 |
排序方式: 共有5702条查询结果,搜索用时 15 毫秒
101.
102.
103.
Ibrahim Hammoud Denise Molina-Gomes Martine Albert Marianne Bergere Marc Bailly Robert Wainer Jacqueline Selva Francois Vialard 《Journal of assisted reproduction and genetics》2010,27(7):423-427
Introduction
Preconception diagnosis requires first polar body biopsy. When the hole in the zona pellucida is made with a laser beam, heat propagation could, like the biopsy itself, be deleterious. Our aim was to evaluate the effect of this technique on human in vitro matured oocyte and embryo development. 相似文献104.
Rauscher Sandrine Lafrance Jean-Philippe Pichette Vincent Bell Robert Z Desforges Katherine Lepage Laurence Ouellet Georges Ouimet Denis Leblanc Martine Lamarche Caroline Bezzaoucha Sarah Vallee Michel 《International urology and nephrology》2017,49(2):325-328
International Urology and Nephrology - The optimal vitamin D3 therapy for the treatment of secondary hyperparathyroidism (SHPT) in chronic hemodialysis patients is still controversial. Recent... 相似文献
105.
Marie Georgelin-Gurgel Franck Diemer Emmanuel Nicolas Martine Hennequin 《Journal of endodontics》2009,35(1):19-22
This observational study compared physiologic and psychological indicators of stress between two groups of 30 healthy patients undergoing either surgical or nonsurgical endodontic treatments. Heart rate (HR), systolic blood pressure (SBP), and diastolic blood pressure were monitored during care sessions. The patients were asked to score their anxiety before treatment and to report pain, stress, and/or discomfort experienced during care. Variations in HR and SBP were significantly dependent on treatment group (HR: F = 6, p < 0.001; SBP: F = 4, p = 0.05). Intergroup differences increased during the active steps of the treatment, such as local anesthesia, rotary instrumentation, periradicular curettage, root filling, and field removal. Moreover, the level of stress experienced during the care procedure was correlated to the level of anticipated anxiety in both groups. This study raises questions on the indications for anxiolysis or sedation in endodontic patients as a means of preventing the neurophysiologic consequences of stress. 相似文献
106.
Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. 总被引:7,自引:0,他引:7
Filip Baert Alain Schmit Geert D'Haens Franceska Dedeurwaerdere Edouard Louis Marc Cabooter Martine De Vos Fernand Fontaine Serge Naegels Piet Schurmans Hedwig Stals Karel Geboes Paul Rutgeerts 《Gastroenterology》2002,122(1):20-25
BACKGROUND & AIMS: Collagenous colitis (CC) is a well-described entity causing chronic diarrhea and characteristic histologic findings. Several treatment options have been suggested, but no controlled data are available. We conducted a placebo-controlled trial to show the clinical and histologic effects of budesonide in CC. METHODS: Twenty-eight patients were randomly assigned to receive placebo (n = 14) or budesonide 9 mg daily (n = 14) for 8 weeks. Patients were evaluated clinically, and blinded biopsy specimens were analyzed from fixed locations at weeks 0 and 8. Clinical response was defined as a decrease of at least 50% in the disease activity score (number of bowel movements in the last 7 days). At week 8, nonresponders received open-label budesonide for the next 8-week period; responders discontinued treatment and were followed up. RESULTS: Three patients discontinued the study prematurely. Intention-to-treat analysis showed clinical response in 8 of 14 patients in the budesonide group compared with 3 of 14 responders for placebo (P = 0.05) after 8 weeks of blinded therapy, together with improved stool consistency. Histologically, there was no change in the mean thickness of the collagen band but a significant decrease of the lamina propria infiltrate in the budesonide group (P < 0.001). CONCLUSIONS: Budesonide is efficacious in inducing short-term clinical response in CC with significant reduction of the histologic infiltrate in the lamina propria. 相似文献
107.
Laurent C Bourgeois A Faye MA Mougnutou R Seydi M Gueye M Liégeois F Kane CT Butel C Mbuagbaw J Zekeng L Mboup S Mpoudi-Ngolé E Peeters M Delaporte E 《The Journal of infectious diseases》2002,186(4):486-492
To compare human immunodeficiency virus (HIV) type 1 disease progression in patients infected by the predominant strain circulating recombinant form (CRF) 02_AG in western and west-central Africa and in patients infected by other strains, a prospective multicenter cohort study was conducted in Cameroon and Senegal. Among the 335 patients, a broad HIV-1 group M subtype diversity was observed in the envelope V3-V5 region, but strain CRF02_AG predominated in both Cameroon and Senegal (61.2% and 62.9%, respectively; P<.8). Multivariate analyses showed no difference between patients infected by CRF02 strains and those infected by other strains in terms of survival (adjusted hazards ratio [HR], 1.16; 95% confidence interval [CI], 0.76-1.78; P=.5), clinical disease progression (HR, 0.79; 95% CI, 0.50-1.25; P=.3), or square root CD4 cell decline (regression coefficient, -0.01; 95% CI, -0.82 to 0.81; P=.9). This study suggests that the predominance of HIV-1 CRF02_AG strain in western and west-central Africa should have no major clinical consequences. 相似文献
108.
BACKGROUND: Chronic constipation (CC) is common and there is a need for more effective and better-tolerated agents that normalize bowel function without affecting secretion. Prucalopride is a novel, selective serotonin(4) receptor agonist with enterokinetic properties. AIMS: Pilot study to compare the efficacy and tolerability of prucalopride and placebo in patients with severe CC referred to a tertiary centre. METHODS: After 4-weeks' run in, patients were randomized to 4 weeks' once daily, double-blind treatment with either prucalopride 4 mg (n = 27) or placebo (n = 26). A 50% dose reduction after 2 weeks' treatment was possible for patients with an excessive gastrointestinal response to the study medication (severe cramps, abdominal pain, and diarrhea). Patients assessed efficacy using a visual analogue scale (VAS) and recorded bowel function in daily diaries. The investigator assessed efficacy and total gut transit time (marker study). RESULTS: Patient VAS assessment demonstrated that prucalopride was significantly more effective than placebo in softening stools, and decreasing straining and time to first stool. Prucalopride also had a positive effect on stool frequency, feeling of complete evacuation and total gut transit time, although these differences were not statistically significant compared with placebo. The most common adverse events were gastrointestinal symptoms and headache; most were mild to moderate. There were no clinically relevant effects on cardiovascular or laboratory parameters. CONCLUSIONS: Once-daily prucalopride 4 mg for 4 weeks is effective and well tolerated in patients with severe CC. It improves whole gut transit, reducing straining, softening stools and reducing time to first bowel movement. 相似文献
109.
110.
Merel Klaassens Deborah Morrogh Elisabeth M Rosser Fatima Jaffer Maaike Vreeburg Levinus A Bok Tim Segboer Martine van Belzen Ros M Quinlivan Ajith Kumar Jane A Hurst Richard H Scott 《European journal of human genetics : EJHG》2015,23(5):610-615
De novo monoallelic variants in NFIX cause two distinct syndromes. Whole gene deletions, nonsense variants and missense variants affecting the DNA-binding domain have been seen in association with a Sotos-like phenotype that we propose is referred to as Malan syndrome. Frameshift and splice-site variants thought to avoid nonsense-mediated RNA decay have been seen in Marshall–Smith syndrome. We report six additional patients with Malan syndrome and de novo NFIX deletions or sequence variants and review the 20 patients now reported. The phenotype is characterised by moderate postnatal overgrowth and macrocephaly. Median height and head circumference in childhood are 2.0 and 2.3 standard deviations (SD) above the mean, respectively. There is overlap of the facial phenotype with NSD1-positive Sotos syndrome in some cases including a prominent forehead, high anterior hairline, downslanting palpebral fissures and prominent chin. Neonatal feeding difficulties and/or hypotonia have been reported in 30% of patients. Developmental delay/learning disability have been reported in all cases and are typically moderate. Ocular phenotypes are common, including strabismus (65%), nystagmus (25% ) and optic disc pallor/hypoplasia (25%). Other recurrent features include pectus excavatum (40%) and scoliosis (25%). Eight reported patients have a deletion also encompassing CACNA1A, haploinsufficiency of which causes episodic ataxia type 2 or familial hemiplegic migraine. One previous case had episodic ataxia and one case we report has had cyclical vomiting responsive to pizotifen. In individuals with this contiguous gene deletion syndrome, awareness of possible later neurological manifestations is important, although their penetrance is not yet clear. 相似文献